Navigation Links
Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results
Date:11/27/2007

------------- -------------

SHAREHOLDERS' EQUITY:

Share capital

Common shares of NIS 0.01 par value

Authorized: 100,000,000 shares at December 31,

2006 and September 30, 2007; Issued and

outstanding: 16,256,514 and 16,423,740

shares at December 31, 2006 and September 30,

2007, respectively 37 37

Additional paid-in capital 65,599 66,340

Accumulated other comprehensive income 958 1,423

Retained earnings 13,209 15,513

------------- -------------

TOTAL SHAREHOLDERS' EQUITY 79,803 83,313

------------- -------------

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $146,996 $160,000

============= =============

(1) Net of allowance for doubtful accounts of $ 1,053 and $ 1,673 as of

December 31, 2006 and September 30, 2007, respectively.

SHAMIR OPTICAL INDUSTRY LTD.

Consolidated Statements of Income

(US dollars in thousands, except per share data)

Three Months Ended Nine Months Ended

September 30, September 30,

------------------------ ------------------------

2006 2007 2006 2007

----------- ----------- ----------- -----------

(Unaudited) (Unaudited) (Unaudited) (Unaudited)

Revenues, net $24,070 $30,934 $71,843 $89,823

Cost of revenues 11,153 14,747 31,933 42,622

--------
'/>"/>

SOURCE Shamir Optical Industry Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Nanofabrication method paves way for new optical devices
2. New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine
3. CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
8. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
9. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
10. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
11. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Israel , Dec. 15, 2014 /PRNewswire/ ... a leading developer of adult stem cell technologies for ... Therapeutics Ltd. was awarded a grant of approximately $1.1 ... the Chief Scientist (OCS).  This is the eighth year ... from the Office of the Chief Scientist, which is ...
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... 12, 2014 The DNA Microarray ... 2013, and is expected to grow at a ... Browse through the TOC of the DNA Microarray ... and segments, with help of various tables and ... DNA Microarray market consists of instrument, consumables, and ...
(Date:12/13/2014)... New York, New York (PRWEB) December 13, 2014 ... expansion of its global network and Cold Chain capabilities, ... new Control Tower in Paris, France, to serve Life ... brand new facility equipped with a controlled-ambient warehouse, will ... in-transit storage for vaccines and investigational drugs, patient-clinical specimens, ...
Breaking Biology Technology:BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2
... Barr Pharmaceuticals,Inc. (NYSE: BRL ) today announced ... Jersey has ruled in favor of its subsidiary, Barr,Laboratories, ... Bayer Schering,Pharma, AG in connection with Bayer Schering,s Yasmin(R) ... Peter G.,Sheridan found that the patent at issue was ...
... Iomai Corporation,(Nasdaq: IOMI ) today announced that ... before the markets open and hold a,conference call and ... March 6, 2008 at 1:30 p.m. Eastern Time., ... call on Thursday, March 6 at 1:30 p.m.,Eastern Time ...
... in a row,the capital markets succumbed to fears of inflation ... the Dow dropped over 300 points after,oil prices pushed past ... was dragged down with the Burrill Biotech Select Index,dropping 4% ... closed down,3%., "The biotech sector started 2008 on a ...
Cached Biology Technology:Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 2Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 3Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 4Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6 2Biotech Drops Amid Tough Markets in February 2Biotech Drops Amid Tough Markets in February 3
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
(Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a leading ... its U.are.U ® fingerprint readers have been deployed ... Central Mexico . The bakery chain ... eliminate payroll issues caused by employees clocking in for ... U.are.U fingerprint readers, Montparnasse relied on paper timecards and ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... Spring Harbor, N.Y. Much like cancer cells, plant ... normal milieu, in culture dishes, have highly unstable genomes. ... help cells cope with challenging culture conditions but inadvertently ... bits of DNA that can jump around in the ...
... change will reach a tipping point in less than ... of the planet,s coral reef ecosystems according to the ... by the Global Coral Reef Monitoring Network and the ... "Status of Coral Reefs of the World: 2008" provides ...
... State University chemist could eventually lead to a quicker ... key to treating a number of diseases, including cancer, ... and research often are made within genetically modified ... to collect into what scientists call inclusion bodies. Those ...
Cached Biology News:CSHL researchers map changing epigenetic modifications that enable transposons to run amok 2Time running out on coral reefs as climate change becomes increasing threat 2Time running out on coral reefs as climate change becomes increasing threat 3
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Proline-serine-threonine phosphatase-interacting protein 2...
Anti-gamma Glutamyl Transferase (gammaGT) Host: mouse monoclonal Species Reactivity: human Applications: WB, IP, FC Storage: 4C...
... Goat polyclonal to Cholesterol Oxidase ... / Specificity Cross-reacts with bacteria. Not ... Information Cholesterol oxidases exist as both ... are implicated in bacterial pathogenesis. In addition, ...
Biology Products: